Blue Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Blue Capital's ABBV Position: Q3 2026 in Review
Blue Capital reduced its AbbVie (ABBV) stake by 0.11% in Q3 2026, selling an estimated $513 and leaving 1,788 shares worth $468K. The position accounts for 0.29% of the portfolio, ranked #90.
Blue Capital first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $513K in Q1 2026. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Blue Capital held 1,788 shares of AbbVie worth $468K as of Q3 2026.
- Blue Capital sold 2 AbbVie shares in Q3 2026, an estimated $513.
- AbbVie made up 0.29% of Blue Capital's portfolio in Q3 2026, its #90 holding.
- Blue Capital first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
- Blue Capital's AbbVie position peaked at $513K in Q1 2026.
- 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.